The Cooper Companies, Inc. with ticker code (COO) have now 13 market analysts covering the stock. The analyst consensus now points to a rating of ‘buy’. The range between the high target price and low target price is between $430.00 and $330.00 with the average target price sitting at $394.08. Given that the stocks previous close was at $335.06 this indicates there is a potential upside of 17.6%. It’s also worth noting that there is a 50 day moving average of $325.23 while the 200 day moving average is $357.22. The market cap for the company is 16.50B. The stock price for the company is currently $333.22 USD
The potential market cap would be $19,409,281,510 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 60.26, revenue per share of $71.07 and a 2.75% return on assets.
The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. CooperVision segment is engaged in developing, manufacturing and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision segment designs its products to solve vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigue, with a broad collection of spherical, toric and multifocal contact lenses. CooperSurgical segment focus on advancing the health of women, babies and families through a diversified portfolio of products and services focusing on women’s health and fertility. CooperSurgical segment supplies the family health care market with a diversified portfolio of products and services. Its office and surgical offerings include products that facilitate surgical and non-surgical procedures that are commonly performed primarily by obstetricians and gynecologists.
